Jump to main content
Jump to site search

Issue 47, 2011
Previous Article Next Article

Design of a magnesium-pridinolum complex for polylactide–drug conjugates formation

Author affiliations

Abstract

Polylactide conjugates of the muscle contraction agent Pridinolum (PriOH = 1,1-diphenyl-3-(1-piperidinyl)-1-propanol) were prepared directly by ring-opening polymerization of L-lactide (L-LA) mediated by the pridinolummagnesium complex [Mg(μ,η2-OPri)(η1-OPri)]2. The ancillary O,N - bifunctional drug as a ligand stabilizes the magnesium species and initiates L-LA polymerization affording a polymer chain terminated by covalently attached drug molecules to the PLLA through ester linkers to form PriO–PLLA conjugate. Up to 80% of the pridinolum can be released from the conjugate by treatment with deuterated hydrochloric acid DCl at pH = 1.5 for 10 h at 37 °C.

Graphical abstract: Design of a magnesium-pridinolum complex for polylactide–drug conjugates formation

Back to tab navigation

Supplementary files

Publication details

The article was received on 17 Aug 2011, accepted on 07 Oct 2011 and first published on 03 Nov 2011


Article type: Communication
DOI: 10.1039/C1DT11545F
Citation: Dalton Trans., 2011,40, 12660-12662
  •   Request permissions

    Design of a magnesium-pridinolum complex for polylactide–drug conjugates formation

    T. Han, J. Utko, L. B. Jerzykiewicz and P. Sobota, Dalton Trans., 2011, 40, 12660
    DOI: 10.1039/C1DT11545F

Search articles by author

Spotlight

Advertisements